Kainos Medicine, Inc. (KOSDAQ:284620)

Kainos Medicine Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 13, 2025	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	35,557	35,557	89,333	120,625	114,482	279,944
Market Cap Growth	-69.37%	-60.20%	-25.94%	5.37%	-59.10%	-40.72%
Enterprise Value	37,375	37,223	89,178	109,730	91,314	275,139
Last Close Price	1087.00	1087.00	3170.00	4320.00	4100.00	11516.11
PS Ratio	30.35	30.35	151.32	451.25	880.46	168.40
PB Ratio	7.72	7.73	10.91	6.32	3.40	15.42
P/TBV Ratio	31.00	31.00	69.45	11.03	4.53	24.53
EV/Sales Ratio	31.90	31.77	151.06	410.49	702.28	165.50
Debt / Equity Ratio	0.03	0.03	0.06	0.02	0.12	0.79
Net Debt / Equity Ratio	-0.59	-0.59	-0.41	-0.84	-0.77	-1.09
Net Debt / EBITDA Ratio	0.43	0.43	0.29	1.03	1.75	1.91
Net Debt / FCF Ratio	0.46	0.46	0.34	0.88	1.98	1.78
Asset Turnover	0.14	0.14	0.04	0.01	0.00	0.04
Quick Ratio	1.57	1.57	1.74	9.16	6.20	1.56
Current Ratio	2.19	2.19	1.93	9.50	6.41	1.67
Return on Equity (ROE)	-121.74%	-121.74%	-89.36%	-57.71%	-61.35%	-94.22%
Return on Assets (ROA)	-49.43%	-49.43%	-49.26%	-35.04%	-24.95%	-18.28%
Return on Capital Employed (ROCE)	-149.10%	-149.10%	-149.60%	-87.60%	-47.40%	-56.50%
Earnings Yield	-21.89%	-21.89%	-13.65%	-12.63%	-13.87%	-5.79%
FCF Yield	-16.66%	-16.66%	-10.87%	-15.10%	-11.46%	-3.98%
Buyback Yield / Dilution	-13.70%	-13.70%	0.33%	-17.14%	-12.49%	-4.59%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.